Injectable Human Growth Hormone
A study on the new drug had been underway for some time and the final results submitted to the FDA for approval revealed that children who took the drug for anywhere between four to six years could sustain a growth in height of anywhere between one to three inches. The final studies also revealed that there appeared to be no health risks for the patients who took the drug.
While many people are excited about the expanded use of this drug, a number of others remain skeptical and fear that it will be used for non-health related issues. There is also a concern over the impact the expanded use of the drug will have on insurance coverage. Currently, the costs for the drug treatment averages around $35,000 per year. Considering that patients are generally required to remain on the treatment plan for an average of five years, the total cost for the treatment plan for just one patient could well reach $175,000 or more.
Since the first forms of the injectable human growth hormone were approved by the FDA, there have continued to be approvals for expanded use of the prescription drug. Today, the supplement has been approved for use in cases of Turner’s syndrome, chronic renal insufficiency, Prader-Willi Syndrome and problems associated with AIDS deterioration.
Research continues in the study of the human growth hormone and other situations in which it could be applied with positive results. Although the FDA has currently not approved the use of the injectable form of the human growth hormone for any other applications, current research interest projects include applications of the human growth hormone in fibromyalgia, chronic fatigue syndrome and even obesity. The athletic industry has particularly been interested in the effects of the human growth hormone since it was first introduced in 1985. In addition, the effect on aging, or anti-aging, is also proving to be a topic of much interest in relation to the human growth hormone.
Since the human growth hormone was first approved for limited use in 1985, there has been an interest in its application for athletes. While the injectable prescription form of the human growth hormone has not been approved for such an application, it is nevertheless widely known and recognized that many athletes do in fact utilize the drug. A study published by Dr. Jenkins of Cambridge University in 2001 noted the results of seven athletes who were each approximately 23 years of age and who began a human growth hormone supplementation while they were in weight training. The study continued over a period of fourteen days and at the end the study revelead that IGF-1 levels were almost doubled. Muscle protein synthesis, however; was not improved or increased.
In Austria , the University of Vienna conducted a similar survey as early as 1993 on men of a similar age group. In this study, the participants were given either an injected human growth hormone dose or a placebo. This study also showed that IGF-1 levels were doubled, however interestingly the muscle gains remained the same between both the placebo and the injectable human growth hormone groups.